Department of Rheumatology , Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hopitaux de Paris, Université Paris-Sud, INSERM U1012 , Le Kremlin Bicêtre , France.
Rheumatology Department , University Hospitals Birmingham NHS Foundation Trust , Birmingham , UK.
RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015.
The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use of the ESSDAI, some domains appear to be more challenging to rate than others. The ESSDAI is now in use as a gold standard to measure disease activity in clinical studies, and as an outcome measure, even a primary outcome measure, in current randomised clinical trials. Therefore, ensuring an accurate and reproducible rating of each domain, by providing a more detailed definition of each domain, has emerged as an urgent need. The purpose of the present article is to provide a user guide for the ESSDAI. This guide provides definitions and precisions on the rating of each domain. It also includes some minor improvement of the score to integrate advance in knowledge of disease manifestations. This user guide may help clinicians to use the ESSDAI, and increase the reliability of rating and consequently of the ability to detect true changes over time. This better appraisal of ESSDAI items, along with the recent definition of disease activity levels and minimal clinically important change, will improve the assessment of patients with primary SS and facilitate the demonstration of effectiveness of treatment for patients with primary SS.
欧洲抗风湿病联盟干燥综合征疾病活动指数(ESSDAI)是一种全身性疾病活动指数,旨在衡量原发性干燥综合征患者的疾病活动度。随着 ESSDAI 的广泛应用,一些领域似乎比其他领域更难评估。ESSDAI 现在被用作临床研究中衡量疾病活动度的金标准,甚至是当前随机临床试验中的主要结局指标。因此,通过为每个领域提供更详细的定义,确保每个领域的评分准确且可重复,已成为当务之急。本文的目的是为 ESSDAI 提供用户指南。本指南对每个领域的评分提供了定义和精度。它还包括对分数的一些微小改进,以整合疾病表现知识的进展。本用户指南可帮助临床医生使用 ESSDAI,并提高评分的可靠性,从而提高随时间检测真实变化的能力。对 ESSDAI 项目的更好评估,以及最近对疾病活动水平和最小临床重要变化的定义,将改善对原发性干燥综合征患者的评估,并促进原发性干燥综合征患者治疗效果的证明。